[Skip to Content]
[Skip to Content Landing]
Article
May 16, 1959

NOMENCLATURE OF BLOOD CLOTTING FACTORS: FOUR FACTORS, THEIR CHARACTERIZATION AND INTERNATIONAL NUMBER

International Committee on Nomenclature of Blood Clotting Factors
Author Affiliations

Members of the Committee are Drs. Irving S. Wright, New York Hospital (chairman); Prof. R. B. Hunter, Department of Pharmacology and Therapeutics, Queen's College, Dundee, Scotland (vice-chairman); T. Abe, Tokyo University Medical College; B. Alexander, Harvard Medical School, Boston; Tage Astrup, Biological Institute, Carlsberg Foundation, Copenhagen; Kenneth Brinkhous, University of North Carolina Medical School, Chapel Hill, N. C.; E. Deutsch, University of Austria Medical School, Vienna; P. Fantl, Baker Medical Institute, Alfred Hospital, Melbourne; H. Hartert, Medizinische Universitatsklinik (Ludolf-Krehl Klinik), Heidelberg, Germany; L. B. Jaques, Department of Physiology, University of Saskatchewan, Saskatoon, Canada; H. Jensen, U. S. Army Medical Research Laboratory, Fort Knox, Ky.; Prof. E. Jorpes, Karolinska Institute, Stockholm; F. Koller, Chefarzt der Medizinischen Abteilung der Krankenanstalt, Neumunster, Zurich, Switzerland; K. Lenggenhager, Direktor der Chirurgische Universitatsklinik, Bern, Switzerland; R. G. Macfarlane, Radcliffe Infirmary, Oxford, England; Willy Merz, University Clinic of Obstetrics and Gynecology of Lausanne, Lausanne, Switzerland; Pietro de Nicola, Pavia, Italy; Prof. P. A. Owren, Overlege, Rikshospitalet Medisinsk, Oslo; Alfredo Pavlovski, Buenos Aires; Armand Quick, Marquette University School of Medicine, Milwaukee; Laszlo Roka, Institute for Vegetativi Physiologie der Universitat, Frankfurt/Main Sud, Germany; Walter Seegers, Wayne University College of Medicine, Detroit; Pierre Soulier, Paris; and Marc Verstraete, Laboratoire de Physiopathologie, Louvain, Belgium (secretary).

JAMA. 1959;170(3):325-328. doi:10.1001/jama.1959.63010030001020
Abstract

Physicians often accuse basic scientists, chemists and physicists in particular, of using a strange language which no one outside their own subject can understand, but at least the majority of physicists or chemists can understand what others in their

own field are talking about. The field of blood coagulation is one in which medical men and biological scientists have created such chaos that they do not even understand what other workers in the field are talking about, far less the clinician or the medical student.

To improve international communications is a worthy object at any time; to do so in the field of clotting factors has proved a task of major difficulty. To bring together the major workers not only from different countries but from the same country, hold them together, and persuade them of the importance of a simple understandable classification has been the problem for the chairman of

×